Unknown

Dataset Information

0

Altered gene expression in pulmonary tissue of tryptophan hydroxylase-1 knockout mice: implications for pulmonary arterial hypertension.


ABSTRACT: The use of fenfluramines can increase the risk of developing pulmonary arterial hypertension (PAH) in humans, but the mechanisms responsible are unresolved. A recent study reported that female mice lacking the gene for tryptophan hydroxylase-1 (Tph1(-/-) mice) were protected from PAH caused by chronic dexfenfluramine, suggesting a pivotal role for peripheral serotonin (5-HT) in the disease process. Here we tested two alternative hypotheses which might explain the lack of dexfenfluramine-induced PAH in Tph1(-/-) mice. We postulated that: 1) Tph1(-/-) mice express lower levels of pulmonary 5-HT transporter (SERT) when compared to wild-type controls, and 2) Tph1(-/-) mice display adaptive changes in the expression of non-serotonergic pulmonary genes which are implicated in PAH. SERT was measured using radioligand binding methods, whereas gene expression was measured using microarrays followed by quantitative real time PCR (qRT-PCR). Contrary to our first hypothesis, the number of pulmonary SERT sites was modestly up-regulated in female Tph1(-/-) mice. The expression of 51 distinct genes was significantly altered in the lungs of female Tph1(-/-) mice. Consistent with our second hypothesis, qRT-PCR confirmed that at least three genes implicated in the pathogenesis of PAH were markedly up-regulated: Has2, Hapln3 and Retlna. The finding that female Tph1(-/-) mice are protected from dexfenfluramine-induced PAH could be related to compensatory changes in pulmonary gene expression, in addition to reductions in peripheral 5-HT. These observations emphasize the intrinsic limitation of interpreting data from studies conducted in transgenic mice that are not fully characterized.

SUBMITTER: Rothman RB 

PROVIDER: S-EPMC3064573 | biostudies-literature | 2011

REPOSITORIES: biostudies-literature

altmetric image

Publications

Altered gene expression in pulmonary tissue of tryptophan hydroxylase-1 knockout mice: implications for pulmonary arterial hypertension.

Rothman Richard B RB   Cadet Jean L JL   Dersch Christina M CM   McCoy Michael T MT   Lehrmann Elin E   Becker Kevin G KG   Bader Michael M   Alenina Natalia N   Baumann Michael H MH  

PloS one 20110325 3


The use of fenfluramines can increase the risk of developing pulmonary arterial hypertension (PAH) in humans, but the mechanisms responsible are unresolved. A recent study reported that female mice lacking the gene for tryptophan hydroxylase-1 (Tph1(-/-) mice) were protected from PAH caused by chronic dexfenfluramine, suggesting a pivotal role for peripheral serotonin (5-HT) in the disease process. Here we tested two alternative hypotheses which might explain the lack of dexfenfluramine-induced  ...[more]

Similar Datasets

| S-EPMC7506791 | biostudies-literature
2003-11-15 | GSE703 | GEO
| S-EPMC7067661 | biostudies-literature
| S-EPMC7752239 | biostudies-literature
| S-EPMC6600981 | biostudies-literature
| S-EPMC6405825 | biostudies-literature
| S-EPMC9967966 | biostudies-literature
| S-EPMC6281741 | biostudies-other
2014-11-14 | E-GEOD-53408 | biostudies-arrayexpress
2020-09-07 | PXD015896 | Pride